CU23795A3 - Formulaciones líquidas de anticuerpo antirrábico - Google Patents
Formulaciones líquidas de anticuerpo antirrábicoInfo
- Publication number
- CU23795A3 CU23795A3 CU20090099A CU20090099A CU23795A3 CU 23795 A3 CU23795 A3 CU 23795A3 CU 20090099 A CU20090099 A CU 20090099A CU 20090099 A CU20090099 A CU 20090099A CU 23795 A3 CU23795 A3 CU 23795A3
- Authority
- CU
- Cuba
- Prior art keywords
- antibody
- antirrabic
- liquid formulations
- formulations
- rabies
- Prior art date
Links
- 239000012669 liquid formulation Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010037742 Rabies Diseases 0.000 abstract 1
- 241000711798 Rabies lyssavirus Species 0.000 abstract 1
- 230000002064 post-exposure prophylaxis Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87289206P | 2006-12-05 | 2006-12-05 | |
| EP06125400 | 2006-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23795A3 true CU23795A3 (es) | 2012-03-15 |
Family
ID=39092188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20090099A CU23795A3 (es) | 2006-12-05 | 2009-06-04 | Formulaciones líquidas de anticuerpo antirrábico |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7959922B2 (enExample) |
| EP (1) | EP2088997B1 (enExample) |
| JP (1) | JP5410985B2 (enExample) |
| KR (1) | KR101522036B1 (enExample) |
| CN (1) | CN101557799B (enExample) |
| AU (1) | AU2007328960B2 (enExample) |
| CA (1) | CA2668947C (enExample) |
| CU (1) | CU23795A3 (enExample) |
| EA (1) | EA017549B1 (enExample) |
| IL (1) | IL199004A (enExample) |
| MX (1) | MX2009005414A (enExample) |
| WO (1) | WO2008068246A1 (enExample) |
| ZA (1) | ZA200902772B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2526284C (en) | 2003-06-25 | 2014-11-18 | Crucell Holland B.V. | Binding molecules for the treatment of myeloid cell malignancies |
| PL2314621T3 (pl) * | 2004-05-27 | 2014-08-29 | Crucell Holland Bv | Cząsteczki wiążące zdolne do neutralizowania wirusa wścieklizny i ich zastosowania |
| CA2881717C (en) | 2006-06-06 | 2018-06-12 | Cecilia Anna Wilhelmina Geuijen | Human binding molecules having killing activity against staphylococci and uses thereof |
| CN101557799B (zh) | 2006-12-05 | 2012-08-22 | 克鲁塞尔荷兰公司 | 液体抗狂犬病抗体制剂 |
| JP2010085126A (ja) * | 2008-09-29 | 2010-04-15 | Adtec Kk | 狂犬病ウイルス中和抗体価判定具および狂犬病ウイルス中和抗体価の測定方法 |
| WO2011028961A2 (en) | 2009-09-04 | 2011-03-10 | Xoma Technology Ltd. | Anti-botulism antibody coformulations |
| US9089529B2 (en) | 2011-10-25 | 2015-07-28 | Prothena Therapeutics Limited | Antibody formulations and methods |
| US9376491B2 (en) * | 2012-03-07 | 2016-06-28 | Eli Lilly And Company | IL-17 antibody formulation and method of treatment using same |
| UA117466C2 (uk) | 2012-12-13 | 2018-08-10 | Мерк Шарп Енд Доме Корп. | СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19 |
| KR20140119396A (ko) | 2013-03-29 | 2014-10-10 | 삼성전자주식회사 | 단백질 약물의 액상 제형 |
| JOP20190260A1 (ar) | 2017-05-02 | 2019-10-31 | Merck Sharp & Dohme | صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها |
| BR112019022873A8 (pt) | 2017-05-02 | 2023-04-11 | Merck Sharp & Dohme | Formulação, e, vaso ou dispositivo de injeção. |
| JP7159642B2 (ja) * | 2018-06-26 | 2022-10-25 | 東ソー株式会社 | カラムの抗体に対する保持力の測定方法 |
| CN113316458B (zh) | 2018-11-07 | 2024-08-02 | 默沙东有限责任公司 | 抗lag3抗体和抗pd-1抗体的共制剂 |
| WO2021249542A1 (en) | 2020-06-12 | 2021-12-16 | Nanjing Leads Biolabs Co., Ltd. | Antibodies binding tnfr2 and uses thereof |
| CN119405798A (zh) * | 2022-04-02 | 2025-02-11 | 重庆智翔金泰生物制药股份有限公司 | 一种治疗狂犬病的抗体药物组合物及其制备方法 |
| CN117771365B (zh) * | 2023-12-07 | 2025-07-04 | 兰州生物制品研究所有限责任公司 | 一种抗狂犬病病毒组合单克隆抗体制剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE99958T1 (de) | 1989-06-08 | 1994-01-15 | Wistar Inst | Monoklonale antikoerper zur behandlung nach einem kontakt mit tollwutvirus. |
| DE4006630A1 (de) | 1990-03-03 | 1991-09-12 | Behringwerke Ag | Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung |
| CA2267139A1 (en) | 1996-10-08 | 1998-04-16 | Ton Logtenberg | Methods and means for selecting peptides and proteins having specific affinity for a target |
| US20040013672A1 (en) | 2000-05-16 | 2004-01-22 | Thomas Jefferson University | Recombinant antibodies, and compositions and methods for making and using the same |
| NZ531291A (en) | 2001-08-21 | 2006-02-24 | Univ Jefferson | Recombinant anti rabies antibodies MAb JB.1 and Mab 57 and compositions and methods for making and using the same |
| PT2314629E (pt) | 2002-07-18 | 2014-01-22 | Merus B V | Produção recombinante de misturas de anticorpos |
| WO2005023849A2 (en) | 2003-09-04 | 2005-03-17 | Crucell Holland B.V. | Antigenic peptides of rabies virus and uses thereof |
| EP1686137A4 (en) * | 2003-10-09 | 2009-10-28 | Chugai Pharmaceutical Co Ltd | PROCESS FOR STABILIZING PROTEIN SOLUTIONS |
| US20070212346A1 (en) * | 2003-10-09 | 2007-09-13 | Tomoyuki Igawa | Highly Concentrated Stabilized Igm Solution |
| JPWO2005063291A1 (ja) * | 2003-12-25 | 2007-07-19 | 麒麟麦酒株式会社 | 抗体を含有する安定な水性医薬製剤 |
| PL2314621T3 (pl) * | 2004-05-27 | 2014-08-29 | Crucell Holland Bv | Cząsteczki wiążące zdolne do neutralizowania wirusa wścieklizny i ich zastosowania |
| CA2604840A1 (en) * | 2005-04-18 | 2006-10-26 | Xtl Biopharmaceuticals Ltd. | Stabilized anti-hepatitis b (hbv) antibody formulations |
| CN101557799B (zh) | 2006-12-05 | 2012-08-22 | 克鲁塞尔荷兰公司 | 液体抗狂犬病抗体制剂 |
-
2007
- 2007-12-04 CN CN2007800448444A patent/CN101557799B/zh not_active Expired - Fee Related
- 2007-12-04 JP JP2009539730A patent/JP5410985B2/ja not_active Expired - Fee Related
- 2007-12-04 WO PCT/EP2007/063244 patent/WO2008068246A1/en not_active Ceased
- 2007-12-04 AU AU2007328960A patent/AU2007328960B2/en not_active Ceased
- 2007-12-04 EA EA200970533A patent/EA017549B1/ru unknown
- 2007-12-04 CA CA2668947A patent/CA2668947C/en active Active
- 2007-12-04 EP EP07847749.4A patent/EP2088997B1/en active Active
- 2007-12-04 KR KR1020097013012A patent/KR101522036B1/ko not_active Expired - Fee Related
- 2007-12-04 MX MX2009005414A patent/MX2009005414A/es active IP Right Grant
- 2007-12-04 US US12/312,967 patent/US7959922B2/en not_active Expired - Fee Related
-
2009
- 2009-04-21 ZA ZA2009/02772A patent/ZA200902772B/en unknown
- 2009-05-27 IL IL199004A patent/IL199004A/en active IP Right Grant
- 2009-06-04 CU CU20090099A patent/CU23795A3/es not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101557799B (zh) | 2012-08-22 |
| JP5410985B2 (ja) | 2014-02-05 |
| MX2009005414A (es) | 2009-06-01 |
| CA2668947A1 (en) | 2008-06-12 |
| JP2010511665A (ja) | 2010-04-15 |
| EP2088997B1 (en) | 2016-08-24 |
| EP2088997A1 (en) | 2009-08-19 |
| AU2007328960A1 (en) | 2008-06-12 |
| KR20090089881A (ko) | 2009-08-24 |
| CA2668947C (en) | 2017-02-07 |
| IL199004A0 (en) | 2010-02-17 |
| ZA200902772B (en) | 2012-09-26 |
| CN101557799A (zh) | 2009-10-14 |
| EA200970533A1 (ru) | 2009-10-30 |
| KR101522036B1 (ko) | 2015-05-20 |
| US20100034829A1 (en) | 2010-02-11 |
| WO2008068246A1 (en) | 2008-06-12 |
| AU2007328960B2 (en) | 2013-01-17 |
| EA017549B1 (ru) | 2013-01-30 |
| US7959922B2 (en) | 2011-06-14 |
| IL199004A (en) | 2015-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23795A3 (es) | Formulaciones líquidas de anticuerpo antirrábico | |
| AR116860A2 (es) | Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas | |
| NO20083895L (no) | Anti-IGF-1R human monoklonalantibody formulering | |
| EP2102238A4 (en) | CD44 ANTIBODY | |
| CY1116261T1 (el) | Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων | |
| CL2008003910A1 (es) | Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida. | |
| EP2501723A4 (en) | HEPATITIS B-VIRUS-SPECIFIC ANTIBODIES AND APPLICATIONS THEREOF | |
| CY1115091T1 (el) | Διειδικες πρωτεϊνες προσδεσης αντιγονων | |
| CY2016030I1 (el) | Αντισωματα εναντι της il-17 | |
| HN2009000379A (es) | Anticuerpo especifico prlr y sus usos | |
| CR10528A (es) | Proceso para producir poxvirus y composiciones de poxvirus | |
| ECSP10010295A (es) | Formulacion de anticuerpo | |
| IL239023A0 (en) | Neutralizing antibodies to influenza viruses | |
| EP2011869A4 (en) | NEW ANTI-CD98 ANTIBODY | |
| FR2921928B1 (fr) | Anticorps monoclonaux specifiques de l'hemagglutinine du virus grippal | |
| BR112014012275A2 (pt) | purificação de proteína com a utilização de tampão bis-tris | |
| CY1114926T1 (el) | Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων | |
| CR11548A (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| EP2490720A4 (en) | ANTI-GCC ANTIBODY MOLECULES AND CORRESPONDING COMPOSITIONS AND METHODS | |
| CL2010001426A1 (es) | Compuestos derivados de triciclos, inhibidores de la proteina quinasa; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades oncologicas e inmunologicas. | |
| BRPI0810851A2 (pt) | Compostos de enxofre com inibidores da serina protease ns3 do vírus da hepatite c | |
| UY31563A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| UY31562A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| UY31560A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| CR10555A (es) | Vacunas para malaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent | ||
| FD | Lapse (for not paying fees) |